Accordingly, the inhibition of STAT3 activity through specific inhibitors induced cell death in the pre-leukaemia cell, and shRNA directed against Stat3 led to a longer latency in pre-B ALL development. The gene discussed is STAT3; the disease is acute lymphoblastic leukemia.